P1-38 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON DISEASE BURDEN IN A CALIFORNIA MEDICAID POPULATION WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE,
P4-18 DISCONTINUATION OF ORAL 5-AMINOSALICYLIC ACID THERAPY ASSOCIATED WITH INCREMENTAL ALL-CAUSE HEALTHCARE COSTS IN ACTIVE ULCERATIVE COLITIS PATIENTS
P4-18 DISCONTINUATION OF ORAL 5-AMINOSALICYLIC ACID THERAPY ASSOCIATED WITH INCREMENTAL ALL-CAUSE HEALTHCARE COSTS IN ACTIVE ULCERATIVE COLITIS PATIENTS